Engineering Dual Active Sites and Defect Structure in Nanozymes to Reprogram Jawbone Microenvironment for Osteoradionecrosis Therapy DOI Creative Commons

Zheng Cheng,

Yuchen Wang,

Haobo Lin

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 17, 2024

Four to eight percent of patients with head and neck cancer will develop osteoradionecrosis the jaw (ORNJ) after radiotherapy. Various radiation-induced tissue injuries are associated reactive oxygen nitrogen species (RONS) overproduction. Herein, Fe doping is used in VO

Language: Английский

Research progress on the synthesis, performance regulation, and applications of Prussian blue nanozymes DOI
Yiyang Wang, Lei Gao, Yue Cao

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: 295, P. 139535 - 139535

Published: Jan. 5, 2025

Language: Английский

Citations

0
Intra-articular injection of MOF-based nanomaterials for the treatment of osteoarthritis by modulating the bone microenvironment DOI Creative Commons
Bing Tan, Yuhao Zheng, Jie Hao

et al.

Advanced Composites and Hybrid Materials, Journal Year: 2025, Volume and Issue: 8(1)

Published: Jan. 17, 2025

Language: Английский

Citations

0
Regulator of oxidative balance: Research progress of nanozymes in ROS-related diseases DOI
Xiang Wang, Zidong Wang, Siyuan Hu

et al.

Materials Today Chemistry, Journal Year: 2025, Volume and Issue: 44, P. 102540 - 102540

Published: Jan. 22, 2025

Language: Английский

Citations

0
Investigation into recent advanced strategies of reactive oxygen species-mediated therapy based on Prussian blue: Conceptualization and prospect DOI
Hee Young Kwon, Yuna Jung, Hojeong Jeon

et al.

Bioactive Materials, Journal Year: 2025, Volume and Issue: 48, P. 71 - 99

Published: Feb. 13, 2025

Language: Английский

Citations

0
Intelligent Nanomaterials Design for Osteoarthritis Managements DOI Open Access
Zhihao Chen, Xuan Zheng, Zhengzhi Mu

et al.

Small Methods, Journal Year: 2025, Volume and Issue: unknown

Published: March 30, 2025

Osteoarthritis (OA) is the most prevalent degenerative joint disorder, characterized by progressive degradation, pain, and diminished mobility, all of which collectively impair patients' quality life escalate healthcare expenditures. Current treatment options are often inadequate due to limited efficacy, adverse side effects, temporary symptom relief, underscoring urgent need for more effective therapeutic strategies. Recent advancements in nanomaterials nanomedicines offer promising solutions improving drug bioavailability, reducing effects providing targeted benefits. This review critically examines pathogenesis OA, highlights limitations existing treatments, explores latest innovations intelligent design OA therapy, with an emphasis on their engineered properties, mechanisms, translational potential clinical application. By compiling recent findings, this work aims inspire further exploration innovation nanomedicine, ultimately advancing development personalized therapies.

Language: Английский

Citations

0
Engineering Dual Active Sites and Defect Structure in Nanozymes to Reprogram Jawbone Microenvironment for Osteoradionecrosis Therapy DOI Creative Commons

Zheng Cheng,

Yuchen Wang,

Haobo Lin

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 17, 2024

Four to eight percent of patients with head and neck cancer will develop osteoradionecrosis the jaw (ORNJ) after radiotherapy. Various radiation-induced tissue injuries are associated reactive oxygen nitrogen species (RONS) overproduction. Herein, Fe doping is used in VO

Language: Английский

Citations

1